New Collaborative Research Center (SFB)
The CRC/Transregio 237 "Nucleic Acid Immunity" is one of three new large-scale projects at the LMU that will be funded by the Deutsche Forschungsgemeinschaft (DFG). The focus of the new CRC/Transregio are mechanisms to detect and eliminate foreign genetic material.
Within the new CRC/Transregio, scientists want to understand the molecular mechanisms of nucleic acid immunity and examine how disturbances of this machinery contribute to the formation of diseases - for example chronic infections and autoimmune diseases. The here-obtained results should also enable the development of new, targeted therapies and therapeutic vaccines.
For more information please visit LMU.de/news